Abbvie Inc
NYSE: ABBV
$162.73
-$1.06 (-0.6%)
Closing price May 6, 2024
ABBV Articles
Here are previews of three pharmaceutical giants set to report earnings before markets open on Friday.
Published:
Wednesday's top analyst upgrades and downgrades included AbbVie, Blackstone, Boston Scientific, CarMax, Chewy, Eli Lilly, Medtronic, NetApp, Ping Identity, Shopify, Veru and Zscaler.
Published:
Wednesday’s additional top analyst upgrades and downgrades included AbbVie, Bristol-Myers, JetBlue, and more.
Published:
These six Dividend Kings make sense for growth and income investors looking for safety and dependability in these turbulent times. They pay the highest dividends and have Buy ratings from top Wall...
Published:
A recent survey of global fund managers found that many have turned to health care for some stability in these uncertain times. These eight high-dividend-paying stocks are rated Buy at top Wall...
Published:
These five Warren Buffett top stock picks are ideal for growth and income investors to consider now, especially in what has become a very volatile and nervous market. They should hold up as interest...
Published:
Here are a few big biopharma names on which Wall Street is growing more bearish.
Published:
Monday's top analyst upgrades and downgrades included AbbVie, Alcoa, Alibaba, Best Buy, Beyond Meat, Block, Coinbase Global, Foot Locker, GoPro, Home Depot, Lithium Americas, Nvidia, TotalEnergies,...
Published:
Thursday afternoon's top analyst upgrades and downgrades included AbbVie, First Solar, The Gap, Qualcomm, Spotify and more.
Published:
We have previewed here three big health care companies, along with the country's largest oil refiner and marketer.
Published:
Friday's top analyst upgrades and downgrades included AbbVie, Chipotle Mexican Grill, Costco Wholesale, Crocs, Dominion Energy, Enphase Energy, Ford, Hertz, KeyCorp, Kite Realty, Riot Blockchain,...
Published:
Wednesday afternoon's top analyst upgrades and downgrades included AbbVie, Biogen, DoorDash, Kratos Defense, PayPal and more.
Published:
These five Dividend Aristocrats are in sectors that have underperformed in 2021 or are solid plays as investors continue to deal with both rising inflation and the potential for rising interest rates...
Published:
Thursday afternoon's top analyst upgrades and downgrades included AbbVie, Allstate, Amgen, Occidental Petroleum, Pfizer, SunPower, Twilio and Yum! Brands.
Published:
Shares of five top established and mature biotechnology and pharmaceutical companies have been hit hard and are offering some of the best entry points in months. The stocks also are rated Buy at top...
Published: